Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection

被引：0
|
作者：
Anai N. Kothari
Sandra R. DiBrito
J. Jack Lee
Abigail S. Caudle
Mark W. Clemens
Vijaya N. Gottumukkala
Matthew H. G. Katz
Anaeze C. Offodile
Abhineet Uppal
George J. Chang
机构：
[1] University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[2] University of Texas MD Anderson Cancer Center,Department of Biostatistics
[3] University of Texas MD Anderson Cancer Center,Department of Breast Surgical Oncology
[4] University of Texas MD Anderson Cancer Center,Department of Plastic Surgery
[5] University of Texas MD Anderson Cancer Center,Department of Anesthesia and Perioperative Medicine
[6] University of Texas MD Anderson Cancer Center,Department of Colon and Rectal Surgery
[7] University of Texas MD Anderson Cancer Center,Data
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8046 / 8053
页数：7
相关论文
共 50 条
  • [1] Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection
    Kothari, Anai N.
    DiBrito, Sandra R.
    Lee, J. Jack
    Caudle, Abigail S.
    Clemens, Mark W.
    Gottumukkala, Vijaya N.
    Katz, Matthew H. G.
    Offodile, Anaeze C.
    Uppal, Abhineet
    Chang, George J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (13) : 8046 - 8053
  • [2] ASO Visual Abstract: Surgical Outcomes for Cancer Patients Undergoing Elective Surgery after Recovering from Mild to Moderate SARS-CoV-2 Infection
    Anai N. Kothari
    Sandra R. DiBrito
    J. Jack Lee
    Abigail S. Caudle
    Mark W. Clemens
    Vijaya N. Gottumukkala
    Matthew H. G. Katz
    Anaeze C. Offodile
    Abhineet Uppal
    George J. Chang
    [J]. Annals of Surgical Oncology, 2021, 28 : 591 - 591
  • [3] ASO Visual Abstract: Surgical Outcomes for Cancer Patients Undergoing Elective Surgery after Recovering from Mild to Moderate SARS-CoV-2 Infection
    Kothari, Anai N.
    DiBrito, Sandra R.
    Lee, J. Jack
    Caudle, Abigail S.
    Clemens, Mark W.
    Gottumukkala, Vijaya N.
    Katz, Matthew H. G.
    Offodile, Anaeze C.
    Uppal, Abhineet
    Chang, George J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 591 - 591
  • [4] Outcomes of Liver Cancer Patients Undergoing Elective Surgery after Recovering from Mild SARS-CoV-2 Omicron Infection: A Retrospective Cohort Study
    Wang, Yizhou
    Ma, Junyong
    Wu, Yali
    Zhang, Shichao
    Li, Xifeng
    Xia, Yong
    Yan, Zhenlin
    Liu, Jian
    Shen, Feng
    Zhang, Xiaofeng
    [J]. CANCERS, 2023, 15 (17)
  • [5] Outcomes of Patients Undergoing Elective Cancer Surgery After SARS-CoV-2 Infection: An Observational Cohort Study
    Li, Zijia
    Shi, Jiankun
    Huang, Qingshan
    Li, Shan
    Cheng, Xingshan
    Mailoga, Nassirou Bizo
    Hu, Qiongyu
    Zhao, Yang
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024,
  • [6] The impact of SARS-Cov-2 Omicron infection on short-term outcomes after elective surgery in patients with gastrointestinal cancer
    Zhang, Di
    Yang, Yao
    Hu, Ren-hao
    Cui, Xi-mao
    Ma, Chi-ye
    Yuan, Biao
    Yan, Dong-yi
    Du, Tao
    Song, Chun
    Jiang, Xiao-hua
    Zhang, Shun
    [J]. UPDATES IN SURGERY, 2024, 76 (04) : 1521 - 1527
  • [7] Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
    Bhangu, Aneel
    [J]. COLORECTAL DISEASE, 2021, 23 (03) : 732 - 749
  • [8] Inhaled aprotinin reduces viral load in mild-to-moderate inpatients with SARS-CoV-2 infection
    Redondo-Calvo, Francisco Javier
    Padin, Juan Fernando
    Martinez-Alarcon, Jose
    Munoz-Rodriguez, Jose Ramon
    Serrano-Oviedo, Leticia
    Lopez-Juarez, Pilar
    Porras Leal, Maria Lourdes
    Gonzalez Gasca, Francisco Javier
    Rodriguez Martinez, Marta
    Perez Serrano, Raul
    Sanchez Cadena, Abraham
    Bejarano-Ramirez, Natalia
    Munoz Hornero, Constanza
    Villegas Fernandez-Infantes, Maria Dolores
    Manrique Romo, Maria Isabel
    Gomez-Romero, Francisco Javier
    Perez-Ortiz, Jose Manuel
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (11)
  • [9] Regdanvimab in patients with mild-to-moderate SARS-CoV-2 infection: A propensity score-matched retrospective cohort study
    Lee, Shinwon
    Lee, Soon Ok
    Lee, Jeong Eun
    Kim, Kye-Hyung
    Lee, Sun Hee
    Hwang, Soyoon
    Kim, Shin-Woo
    Chang, Hyun-Ha
    Kim, Yoonjung
    Bae, Sohyun
    Kim, A-Sol
    Kwon, Ki Tae
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 106
  • [10] Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
    Chansavath Phetsouphanh
    David R. Darley
    Daniel B. Wilson
    Annett Howe
    C. Mee Ling Munier
    Sheila K. Patel
    Jennifer A. Juno
    Louise M. Burrell
    Stephen J. Kent
    Gregory J. Dore
    Anthony D. Kelleher
    Gail V. Matthews
    [J]. Nature Immunology, 2022, 23 : 210 - 216
12345